Sunday, 19 May 2024
Trending

Investing

Waters Corp price target raised to $358 on pharma demand outlook By Investing.com

Amended & Restated Technical Report to Support Kharmagtai Preliminary Economic Assessment By Investing.com


On Wednesday, TD Cowen adjusted its price target for Waters Corporation (NYSE:), a specialty measurement company, raising it to $358 from the previous target of $350. The firm maintained its Hold rating on the stock. This adjustment follows Waters Corp ‘s announcement of a modest revenue beat for the first quarter and a reiteration of its 2024 guidance, despite a forecasted weaker second quarter.

The company’s stock closed 2% higher after the earnings report was released. Management’s commentary highlighted that pharmaceutical budgets and orders have become more stable, and customer feedback indicates an improvement in demand from the pharmaceutical sector. Additionally, Waters Corp experienced a stronger performance in China, showing early signs of a turnaround.

However, the chemicals and industrial sectors were noted as weak, continuing to pose a risk. Despite uncertainties, the 2024 guidance was supported by the company’s order book and customer relationship management system, aligning with historical patterns. Nevertheless, investors still have questions regarding the future performance.

Waters Corp’s recent developments come in the context of the broader market’s search for signs of stability in various sectors, with particular attention to the impact of global economic conditions on companies like Waters. The company’s focus on analytical technologies for the life sciences industry makes its performance an indicator of trends within this specific market segment.

InvestingPro Insights

Following the recent earnings report and guidance reiteration by Waters Corporation (NYSE:WAT), insights from InvestingPro provide a deeper look into the company’s valuation and performance metrics. With a market capitalization of $19.41 billion and a P/E ratio of 31.99, Waters Corp is trading at a high earnings multiple, which is slightly adjusted to 30.18 when looking at the last twelve months as of Q1 2024. This suggests that the market has robust expectations for the company’s earnings potential.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.

An InvestingPro Tip indicates that analysts have revised their earnings expectations downwards for the upcoming period, which could be a point of concern for potential investors. Additionally, the company’s stock has experienced a significant price uptick of 27.46% over the last six months, indicating strong market sentiment. Despite this recent growth, the company does not pay…

Click Here to Read the Full Original Article at All News…